Clinical Value of Peripheral Blood Gene Expression Profile and dd-cfDNA for Identifying Persistent Rejection.
Raymond L HeilmanJames N FlemingSook H ParkChristabel RebelloSteve KleiboekerJohn HolmanJohn J FriedewaldPublished in: Kidney360 (2024)
Both GEP and dd-cfDNA may have utility at identifying clinically stable patients with persistent rejection in need of biopsy, however they identify different types of rejection.